Anixa Biosciences ANIX Stock
Anixa Biosciences Price Chart
Anixa Biosciences ANIX Financial and Trading Overview
| Anixa Biosciences stock price | 3.1 USD |
| Previous Close | 3.26 USD |
| Open | 3.36 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 3.26 - 3.41 USD |
| 52 Week Range | 2.77 - 6.45 USD |
| Volume | 25.34K USD |
| Avg. Volume | 94.24K USD |
| Market Cap | 105.45M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.5 USD |
ANIX Valuation Measures
| Enterprise Value | 73.3M USD |
| Trailing P/E | N/A |
| Forward P/E | 1.647343 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 502.1615 |
| Price/Book (mrq) | 3.9376445 |
| Enterprise Value/Revenue | 349.07 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Anixa Biosciences Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 9.64% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.45 USD |
| 52 Week Low | 2.77 USD |
| 50-Day Moving Average | 3.95 USD |
| 200-Day Moving Average | 4.46 USD |
ANIX Share Statistics
| Avg. Volume (3 month) | 94.24K USD |
| Avg. Daily Volume (10-Days) | 45.54K USD |
| Shares Outstanding | 30.92M |
| Float | 29.57M |
| Short Ratio | 7.89 |
| % Held by Insiders | 4.53% |
| % Held by Institutions | 11.78% |
| Shares Short | 630.79K |
| Short % of Float | 2.13% |
| Short % of Shares Outstanding | 2.03% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | April 30, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -5486.66% |
| Gross Margin | 23.33% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.84% |
| Return on Equity (ttm) | -38.25% |
Income Statement
| Revenue (ttm) | 210K USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -10832000 USD |
| Diluted EPS (ttm) | -0.4 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 26.98M USD |
| Total Cash Per Share (mrq) | 0.87 USD |
| Total Debt (mrq) | 198K USD |
| Total Debt/Equity (mrq) | 0.76 USD |
| Current Ratio (mrq) | 17.833 |
| Book Value Per Share (mrq) | 0.866 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5784000 USD |
| Levered Free Cash Flow (ttm) | -169250 USD |
Profile of Anixa Biosciences
| Country | United States |
| State | CA |
| City | San Jose |
| Address | 3150 Almaden Expressway |
| ZIP | 95118 |
| Phone | 408 708 9808 |
| Website | https://www.anixa.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Q&A For Anixa Biosciences Stock
What is a current ANIX stock price?
Anixa Biosciences ANIX stock price today per share is 3.1 USD.
How to purchase Anixa Biosciences stock?
You can buy ANIX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Anixa Biosciences?
The stock symbol or ticker of Anixa Biosciences is ANIX.
Which industry does the Anixa Biosciences company belong to?
The Anixa Biosciences industry is Biotechnology.
How many shares does Anixa Biosciences have in circulation?
The max supply of Anixa Biosciences shares is 32.62M.
What is Anixa Biosciences Price to Earnings Ratio (PE Ratio)?
Anixa Biosciences PE Ratio is now.
What was Anixa Biosciences earnings per share over the trailing 12 months (TTM)?
Anixa Biosciences EPS is -0.34 USD over the trailing 12 months.
Which sector does the Anixa Biosciences company belong to?
The Anixa Biosciences sector is Healthcare.
Anixa Biosciences ANIX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}